Loading...

Consumer Health Trends Will Foster Global Market Expansion

Published
08 Aug 24
Updated
04 Oct 25
AnalystConsensusTarget's Fair Value
US$82.46
19.2% undervalued intrinsic discount
04 Oct
US$66.66
Loading
1Y
-17.8%
7D
-2.4%

Author's Valuation

US$82.4619.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on04 Oct 25
Fair value Decreased 1.66%

McCormick's analyst price target has been revised downward by analysts from $83.86 to $82.46, reflecting lower profit margin expectations and cautious views around upcoming earnings because of continued market pressures. Analyst Commentary Recent research coverage for McCormick reflects a mixture of optimism for the company's long-term growth prospects and caution surrounding short-term financial pressures.

Shared on07 May 25
Fair value Increased 1.76%

Shared on30 Apr 25
Fair value Decreased 0.31%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 0.40%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 1.06%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.33%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.37%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.31%

AnalystConsensusTarget has increased revenue growth from 2.9% to 3.3%.

Shared on19 Mar 25
Fair value Increased 0.52%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on10 Mar 25
Fair value Increased 0.51%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.